15 programming-language Postdoctoral positions at The Ohio State University in United States
-
and Sciences | Physics Administration Post Doctoral Scholar will carry out a vigorous program of independent research, write papers for refereed publication, travel to conferences and other venues
-
(or a related field), is proficient in both mechanistic modeling and ML frameworks (e.g., TensorFlow, PyTorch), and has strong programming skills (Python/MATLAB/C++). Join us to tackle sustainability
-
supporting documentation via Workday with their application, including: Cover letter describing your research background, fit for the AquOTic program, including comfort in water-based environments, research
-
metagenomic sequencing data. Strong programming skills (e.g., R and Python). Experience with cloud computing. Excellent organizational and interpersonal skills, and a strong publication record. Desired
-
production with an associated photon. • Technical skills in the use of columnar analysis approaches with python. Desired Qualifications • Experience with C++ programming. • Experience in developing
-
. - Two-page research statement describing your vision and research plan in the domains of risk and resilience analytics and digital twin modeling, highlighting both technical depth and innovative thinking
-
. Possess excellent verbal and written communication skills in English. Exhibit research interest in areas such as STEM higher education, graduate student and faculty retention, mixed methods research
-
in the scientific field and accounts for previously unexplained phenomena for new and/or continuing research projects; participate in determining priorities and planning research programs; carry out
-
scientific mentor in the Department of Neurology; plan, design and execute experiments of considerable scope and complexity in the assigned research lab; collect and analyzes data for research sponsored by
-
member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01